Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
Current assets:    
Cash and cash equivalents $ 13,415 $ 17,528
Marketable securities, available for sale, fair value 1,244  
Accounts receivable, net of allowance for doubtful accounts of $841 and $500 at January 31, 2023 and January 31, 2022, respectively 10,382 8,819
Unbilled receivables, net 7,757 9,160
Prepaid expenses and other current assets 2,314 2,310
Total current assets 35,112 37,817
Property and equipment, net 713 902
Operating lease right-of-use assets 1,360 2,031
Goodwill   9,882
Unbilled receivables, net 5,044 3,952
Other assets 430 612
Total assets 42,659 55,196
Current liabilities:    
Accounts payable 1,541 2,960
Accrued expenses 3,813 4,217
Deferred revenue 5,172 3,947
Total current liabilities 10,526 11,124
Deferred revenue 130 77
Operating lease liabilities 691 1,361
Taxes payable 98 110
Other liabilities 3  
Total liabilities 11,448 12,672
Commitments and contingencies (Note 7)
Stockholders' equity:    
Common stock, $0.01 par value per share; 100,000,000 shares authorized; 50,386,378 shares issued and 50,214,458 shares outstanding at January 31, 2023; 49,347,604 shares issued and 49,175,684 shares outstanding at January 31, 2022 503 493
Additional paid-in capital 266,642 265,644
Treasury stock, at cost; 171,920 shares at January 31, 2023 and 2022 (227) (227)
Accumulated other comprehensive loss (1,890) (973)
Accumulated deficit (233,817) (222,413)
Total stockholders' equity 31,211 42,524
Total liabilities and stockholders' equity $ 42,659 $ 55,196